-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q1 2023 to Q1 2024.
- ELITE PHARMACEUTICALS INC /NV/ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Mar 2024 was $24,293,000, a 1018% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)